Regulatory Red Flags: Fixing Common Submission Gaps Before They Derail Your Device Approval

This episode unpacks the most common and costly documentation mistakes that medical device manufacturers make in their regulatory submissions. We explore specific gaps frequently flagged by Notified Bodies and the FDA, focusing on the Clinical Evaluation Report (CER), risk management files, and Post-Market Clinical Follow-up (PMCF) plans. Learn how to identify these deficiencies in your own technical files and, more importantly, how to fix them quickly to avoid delays and ensure a smoother path to market approval. • What are the most frequent deficiencies found in Clinical Evaluation Reports under the EU MDR? • How can you make your safety and performance objectives specific and measurable? • What does a truly comprehensive "State of the Art" section look like? • Are your equivalence claims strong enough to pass regulatory scrutiny? • Is your literature search protocol systematic and reproducible? • Why is a "living" risk management file essential for compliance? • Are you properly integrating post-market surveillance data into your technical documentation? • How do you write a justification for not conducting a PMCF study that regulators will accept? • What simple changes can you make to your documentation process to avoid common pitfalls? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.